CN102008569B - Traditional Chinese medicine preparation for treating chronic prostatitis - Google Patents
Traditional Chinese medicine preparation for treating chronic prostatitis Download PDFInfo
- Publication number
- CN102008569B CN102008569B CN201010587198XA CN201010587198A CN102008569B CN 102008569 B CN102008569 B CN 102008569B CN 201010587198X A CN201010587198X A CN 201010587198XA CN 201010587198 A CN201010587198 A CN 201010587198A CN 102008569 B CN102008569 B CN 102008569B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- chronic prostatitis
- traditional chinese
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 201000007094 prostatitis Diseases 0.000 title abstract description 19
- 239000003814 drug Substances 0.000 title abstract description 18
- 208000013507 chronic prostatitis Diseases 0.000 title abstract description 17
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 239000008280 blood Substances 0.000 abstract description 16
- 230000001737 promoting effect Effects 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 12
- 210000003734 kidney Anatomy 0.000 abstract description 8
- 210000004185 liver Anatomy 0.000 abstract description 7
- 239000004863 Frankincense Substances 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000000582 semen Anatomy 0.000 description 6
- 241000717739 Boswellia sacra Species 0.000 description 5
- 241001057584 Myrrha Species 0.000 description 5
- 230000004087 circulation Effects 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 210000002307 prostate Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000002559 palpation Methods 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010057409 Prostate tenderness Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 210000004908 prostatic fluid Anatomy 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine preparation for treating chronic prostatitis, which is used for reducing complications and recurrence. The traditional Chinese medicine is prepared from the following traditional Chinese medicine raw materials in parts by weight: 6-15 parts of red paeony root, 6-12 parts of medicinal cyathula root, 9-15 parts of eucommia bark, 30-35 parts of dandelion, 15-30 parts of herba patriniae, 6-10 parts of peach kernel, 6-12 parts of cowherb seed, 10-15 parts of salvia miltiorrhiza, 6-12 parts of herba lycopi, 3-9 parts of frankincense, 3-9 parts of myrrh, 5-10 parts of szechwan chinaberry fruit, 10-15 parts of glossy privet fruit, 6-15 parts of Chinese angelica and 3-9 parts of szechuan. The invention has the functions of nourishing kidney and liver, clearing away heat and toxic material, cooling blood and promoting blood circulation as well as promoting blood circulation and removing blood stasis, and has better treatment effect on chronic prostatitis. The traditional Chinese medicine preparation is used for treating 139 patients with chronic prostatitis, wherein the cure rate is 110 (79.1%), the improvement rate is 19 (13.7%) and the ineffective rate is 10 (7.2%).
Description
Technical field
The invention belongs to the pharmaceutical product technical field, particularly a kind of Chinese medicine preparation of treating chronic prostatitis.
Background technology
Chronic prostatitis is a kind of sickness rate very high (4%~25%) and lets the very puzzled disease of people that the man near 50% is in its influence that will suffer from the prostatitis symptom sometime in life.Because its cause of disease, pathological change, clinical symptoms complicacy are various, and have certain influence to male's sexual function and reproductive function, seriously influenced patient's quality of life, make patient's the spirit and the human body suffer great torment.The symptom of common chronic prostatitis has urethra scorching hot, hypogastric region and perineal position swelling and pain, frequent micturition, urgent micturition, waist soreness, weak, insomnia, forgetful, seminal emission, sexual impotence and premature ejaculation etc.Chronic prostatitis also can cause following complication simultaneously: 1, influence sexual function and cause sexual impotence.2, influence fertility can cause sterile.3, cause chronic nephritis, even can develop into uremia.
At present, the Chinese and western drugs of treatment chronic prostatitis is a lot, like Chinese patent medicine Kang Lieshule, but many people's easy relapse is arranged.
Summary of the invention
The object of the invention provides a kind of Chinese medicine preparation of treating chronic prostatitis, to reduce complication and less recurrence.
A kind of Chinese medicine preparation of treating chronic prostatitis, it is to adopt the raw material of Chinese medicine of following weight ratio to process:
Radix Paeoniae Rubra 6-15, Radix Cyathulae 6-12, Cortex Eucommiae 9-15, Herba Taraxaci 30-35, Herba Patriniae 15-30, Semen Persicae 6-10, king do not stay 6-12, Radix Salviae Miltiorrhizae 10-15, Herba Lycopi 6-12, Olibanum 3-9, Myrrha 3-9, Fructus Toosendan 5-10, Fructus Ligustri Lucidi 10-15, Radix Angelicae Sinensis 6-15, Rhizoma Chuanxiong 3-9.
The preparation that the present invention recommends adopts the raw material of Chinese medicine of following weight ratio to process:
Radix Paeoniae Rubra 15, Radix Cyathulae 9, the Cortex Eucommiae 13, Herba Taraxaci 35, Herba Patriniae 15, Semen Persicae 6, king do not stay 9, Radix Salviae Miltiorrhizae 13, Herba Lycopi 9, Olibanum 9, Myrrha 9, Fructus Toosendan 6, Fructus Ligustri Lucidi 13, Radix Angelicae Sinensis 13, Rhizoma Chuanxiong 6.
The effect of each component is among the present invention: Radix Paeoniae Rubra-removing heat from blood and promoting blood circulation, stasis-dispelling and pain-killing, liver heat removing and eyesight improving; Radix Cyathulae-promoting blood circulation to restore menstrual flow, the sharp numbness of Shujin, conducting blood to flow downwards, inducing diuresis for treating stranguria syndrome; The Cortex Eucommiae-invigorating the liver and kidney, Gu bone and muscle strengthening is through calming the nerves blood pressure lowering; Herba Taraxaci-heat-clearing and toxic substances removing, liver heat removing and eyesight improving; Herba Patriniae-heat-clearing and toxic substances removing, the evacuation of pus of row expectorant; Semen Persicae-removing blood stasis with potent drugs promoting the circulation of blood is moisturized laxation; The king does not stay-the lactogenesis detumescence, promoting blood circulation to restore menstrual flow; Radix Salviae Miltiorrhizae-blood circulation promoting and blood stasis dispelling, relieving restlessness is calmed the nerves, reducing swelling and alleviating pain; Herba Lycopi-blood circulation promoting and blood stasis dispelling, line water detumescence; Olibanum-promoting blood circulation and stopping pain, detumescence and promoting granulation, muscle relaxing collaterals activating; Myrrha-promoting blood circulation and stopping pain, detumescence and promoting granulation; Fructus Toosendan-promoting the circulation of QI to relieve pain, anthelmintic; Fructus Ligustri Lucidi-nourishing kidney the liver benefiting, black hair makes eye bright; Radix Angelicae Sinensis-tonifying blood and regulating menstruation, promoting blood circulation and stopping pain, loosening bowel to relieve constipation; Rhizoma Chuanxiong-blood-activating and qi-promoting, wind-expelling pain-stopping.
The present invention has the effect of nourishing kidney the liver benefiting, heat-clearing and toxic substances removing, removing heat from blood and promoting blood circulation and blood circulation promoting and blood stasis dispelling, and chronic prostatitis is had therapeutical effect preferably.Chinese medicine preparation treatment patients with chronic prostatitis 139 examples of the present invention, routine 110 examples of fully recovering (accounting for 79.1%), 19 examples that take a turn for the better (accounting for 13.7%), invalid 10 examples (accounting for 7.2%).
The specific embodiment
Prescription 1: Radix Paeoniae Rubra 15g, Radix Cyathulae 9g, Cortex Eucommiae 13g, Herba Taraxaci 35g, Herba Patriniae 15g, Semen Persicae 6g, king do not stay 9g, Radix Salviae Miltiorrhizae 13g, Herba Lycopi 9g, Olibanum 9g, Myrrha 9g, Fructus Toosendan 6g, Fructus Ligustri Lucidi 13g, Radix Angelicae Sinensis 13g, Rhizoma Chuanxiong 6g.Each component cleans up the back pulverizing and processes pill according to routine.
Prescription 2: Radix Paeoniae Rubra 6, Radix Cyathulae 12, the Cortex Eucommiae 9, Herba Taraxaci 35, Herba Patriniae 15, Semen Persicae 10, king do not stay 6, Radix Salviae Miltiorrhizae 15, Herba Lycopi 6, Olibanum 9, Myrrha 3, Fructus Toosendan 10, Fructus Ligustri Lucidi 10, Radix Angelicae Sinensis 15, Rhizoma Chuanxiong 3.Each component is in the gram weight, and extractum is processed powder behind each component water extraction.
Prescription 3: Radix Paeoniae Rubra 15, Radix Cyathulae 6, the Cortex Eucommiae 15, Herba Taraxaci 30, Herba Patriniae 30, Semen Persicae 6, king do not stay 12, Radix Salviae Miltiorrhizae 10, Herba Lycopi 12, Olibanum 3, Myrrha 9, Fructus Toosendan 5, Fructus Ligustri Lucidi 15, Radix Angelicae Sinensis 6, Rhizoma Chuanxiong 9.Each component is in the gram weight, and each component water extract is processed capsule.
Chinese medicine preparation treatment patients with chronic prostatitis 139 examples of the present invention, respond well, existing report as follows.
1, clinical data: 24~66 years old this group age, the course of disease 2 months to 3 years.Have more and take various antibiotic histories for a long time, part patient's treatment that once took traditional Chinese medicine.Diagnosis meets following standard: 1. frequent micturition, urgent micturition, dysurea, and the urethra burn feeling, urethral orifice often has secretions, anus, perineum, sagging distention in the smaller abdomen pain; 2. rectal touch prostate tenderness, prostate increase, normal or dwindle; 3. massage of prostate liquid (EPS) microscopy lecithin reduces or disappears, and leukocyte or pus cell increase.
2, Therapeutic Method: according to clinical symptoms, oral each 6 grams are equivalent to the preparation (preparation is according to the decision of patient's situation) of former medicine, and every day 3 times, be 15 days the course of treatment.
3, curative effect is judged: according to the criterion of cure of chronic prostatitis: (1). subjective symptoms disappears.(2). the normal or improvement of prostate during palpation.(3). the test of location segmentation urine is normal.(4). examination of prostatic fluid is normal, and antibacterial culturing is negative, and lecithin is the preceding showed increased of treatment (all negative credibility that just more can prove its therapeutic effect of objective determination more than 2 times).
It is normal for fully recovering more than 2 times that above clinical symptom disappearance, prostate palpation are recovered normal EPS microscopy; Symptom, sign, EPS microscopy transfer produce effects well to; Above-mentioned indication do not have change into invalid.
4, therapeutic outcome: this group recovery from illness routine 110 examples (accounting for 79.1%) in 139,19 examples that take a turn for the better (accounting for 13.7%), invalid 10 examples (accounting for 7.2%).
5, conclusion: the traditional Chinese medical science thinks that the cause of disease of prostatitis has intemperance of taking food more, and excessive drinking or chamber are unclean, causes damp and hot interior giving birth to, and accumulates in smart chamber; Or the diseases caused by exogenous pathogenic factor pyretic toxicity, do not pent up and loose, the multiple abscess part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, stagnation of QI-blood, passages through which vital energy circulates intercepts, and functioning of bladder is unfavorable, forms the card of stranguria with turbid discharge; Or sexual life too, or bear by force and do not let out, and causes the kidney essense loss, hyperactivity of fire caused by deficiency of YIN, hyperactivity of the ministerial fire, the priming part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels damp and hot and cause this disease.The present invention has the effect of nourishing kidney the liver benefiting, heat-clearing and toxic substances removing, removing heat from blood and promoting blood circulation and blood circulation promoting and blood stasis dispelling, and chronic prostatitis is had therapeutical effect preferably.
Claims (2)
1. Chinese medicine preparation of treating chronic prostatitis is characterized in that adopting the raw material of Chinese medicine of following weight ratio to process:
Radix Paeoniae Rubra 6-15, Radix Cyathulae 6-12, Cortex Eucommiae 9-15, Herba Taraxaci 30-35, Herba Patriniae 15-30, Semen Persicae 6-10, king do not stay 6-12, Radix Salviae Miltiorrhizae 10-15, Herba Lycopi 6-12, Olibanum 3-9, Myrrha 3-9, Fructus Toosendan 5-10, Fructus Ligustri Lucidi 10-15, Radix Angelicae Sinensis 6-15, Rhizoma Chuanxiong 3-9.
2. a kind of Chinese medicine preparation of treating chronic prostatitis according to claim 1 is characterized in that adopting the raw material of Chinese medicine of following weight ratio to process:
Radix Paeoniae Rubra 15, Radix Cyathulae 9, the Cortex Eucommiae 13, Herba Taraxaci 35, Herba Patriniae 15, Semen Persicae 6, king do not stay 9, Radix Salviae Miltiorrhizae 13, Herba Lycopi 9, Olibanum 9, Myrrha 9, Fructus Toosendan 6, Fructus Ligustri Lucidi 13, Radix Angelicae Sinensis 13, Rhizoma Chuanxiong 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010587198XA CN102008569B (en) | 2010-12-14 | 2010-12-14 | Traditional Chinese medicine preparation for treating chronic prostatitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010587198XA CN102008569B (en) | 2010-12-14 | 2010-12-14 | Traditional Chinese medicine preparation for treating chronic prostatitis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102008569A CN102008569A (en) | 2011-04-13 |
CN102008569B true CN102008569B (en) | 2012-04-18 |
Family
ID=43839031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010587198XA Expired - Fee Related CN102008569B (en) | 2010-12-14 | 2010-12-14 | Traditional Chinese medicine preparation for treating chronic prostatitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102008569B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102949537B (en) * | 2011-08-27 | 2014-12-03 | 齐建敏 | Chinese medicament for treating prostatitis |
CN102579754A (en) * | 2012-02-21 | 2012-07-18 | 简福川 | Chinese medicament for treating qi stagnation and blood stasis type prostatitis |
CN102626458B (en) * | 2012-02-28 | 2013-07-17 | 余谨文 | Urologic anti-inflammation pill |
CN102755563B (en) * | 2012-04-26 | 2013-12-18 | 中国中医科学院广安门医院 | Traditional Chinese medicine composition for treating chronic prostatitis and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1330347C (en) * | 2001-11-29 | 2007-08-08 | 廖干甫 | Gongbu ointment |
CN100553667C (en) * | 2007-06-06 | 2009-10-28 | 赵善军 | The Chinese medicinal liquor of strengthening physique, refreshing and improving sexual fuction |
CN101804169A (en) * | 2010-05-28 | 2010-08-18 | 泰一和浦(北京)中医药研究院有限公司 | Traditional Chinese medicine composition for treating urinary incontinence and preparation method thereof |
-
2010
- 2010-12-14 CN CN201010587198XA patent/CN102008569B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102008569A (en) | 2011-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101732660B (en) | Chinese medicinal preparation for treating prostate disease and preparation method thereof | |
CN102228603B (en) | Chinese medicine for treating retention of urine | |
CN102058715B (en) | Chinese medicine preparation for treating chronic prostatitis and preparation method thereof | |
CN102008569B (en) | Traditional Chinese medicine preparation for treating chronic prostatitis | |
CN104225319A (en) | Traditional Chinese preparation for treating acute renal failure | |
CN103417860B (en) | Traditional Chinese herbal preparation for treating prostatitis and diseases of urinary system | |
CN103070995A (en) | Traditional Chinese medicine for curing prostatitis | |
CN103768478A (en) | Traditional Chinese medicine composition for treating prostatitis and preparation method and application thereof | |
CN102935214B (en) | Traditional Chinese medicinal composition for treating uremia | |
CN102698126B (en) | Traditional Chinese medicine compound having effect of treating prostatitis and preparation method thereof | |
CN100435840C (en) | Medicament for treating hyperplasia of prostate | |
CN103656063A (en) | Medicine for treating chronic prostatitis | |
CN100493521C (en) | Medicine for treating venereal disease and production method | |
CN104587017B (en) | A kind of Clearing heat and removing obstruction of fu-organs, pharmaceutical composition of the promoting flow of qi and blood circulation and its production and use | |
CN102228643A (en) | Traditional Chinese medicine composition for treating chronic prostatitis | |
CN103157048A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation and preparation method thereof | |
CN102940674B (en) | Medicine composition for treating benign prostatic hyperplasia | |
CN102824573B (en) | Medicine for treating prostatic diseases | |
CN101112497A (en) | A kind of medicine for treating prostatitis and preparation method thereof | |
CN105477264A (en) | Medicinal preparation for treating urethral syndrome | |
CN102363015B (en) | Compound detoxifying pill | |
CN103301316B (en) | Traditional Chinese medicine composition for treating Intermin-gled phlegm and blood stasis syndrome globus hystericus | |
CN104189539A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
CN101439110B (en) | Chinese medicine for curing rheumatism | |
CN104721638A (en) | Traditional Chinese medicine preparation used for treating prostatitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120418 Termination date: 20121214 |